Month: February 2021

Pressmeddelande24 februari 2021, 18:15Styrelseordföranden i Sdiptech AB (publ) förvärvar aktier via lösen av köpoptionerSdiptechs styrelseordförande Jan Samuelson har förvärvat 90 000 aktier i Sdiptech AB med stöd av köpoptioner från Serendipity Group AB.Sdiptech har informerats om att Jan Samuelson påkallat lösen av köpoptioner utställda av Serendipity Group. Köpoptionerna som förvärvades 2018 ger Jan Samuelson rätt att köpa 90 000 B-aktier i Sdiptech från Serendipity Group.Då Serendipity Group för närvarande inte äger några aktier i Sdiptech förvärvar bolaget motsvarande antal aktier från sina ägare, Ashkan Pouya och Saeid Esmaeilzadeh via bolag, som därmed minskar sina innehav i Sdiptech med 45 000 aktier vardera.Jan Samuelson flyttar därtill 45 000 aktier av sitt nuvarande innehav från en depå i sitt eget namn, till sitt bolag Independia...

Financial statement release on 24 February 2021 at 7:15 p.m. (CET)BBS- Bioactive Bone Substitutes Plc’s (“BBS”, “the Company”) Financial Statements Review 1.1.-31.12.2020 (unaudited)Year 2020 in brief (Reference period 2019)Clinical study results were received in February and they were confirmed to fulfil the Company goals. The ARTEBONE® Paste works clinically as well as human autograft.BBS’ patent application”A METHOD FOR PREPARING A BONE PROTEIN PREPARATION AND A BONE PROTEIN PREPARATION” for the product had been accepted in the USA. The Company’s product ARTEBONE® is now patented in all the countries where it has been applied for. The patent application regarding the production is still in progress in the USA.Covid-19 pandemic caused considerable delays in the Company actions.Considerable deficiencies were discovered in the documentation...

BBS-Bioactive Bone Substitutes Oyj: Tilinpäätöstiedote 1.1.2020 – 31.12.2020 (Tilintarkastamaton)Tilinpäätöstiedote 24.2.2021 klo 19.00 (CET)BBS-Bioactive Bone Substitutes Oyj:n (“BBS”, “Yhtiö”) Tilinpäätöstiedote 1.1.2020 – 31.12.2020 (tilintarkastamaton)Vuosi 2020 lyhyesti (vertailukausi 2019)Kliinisen kokeen tulokset saatiin helmikuussa ja niiden voitiin todeta olevan Yhtiön tavoitteiden mukaisia. ARTEBONE® Paste toimii kliinisesti yhtä hyvin kuin ihmisen oma luusiirre.BBS:n patenttihakemuksen ”A METHOD FOR PREPARING A BONE PROTEIN PREPARATION AND A BONE PROTEIN PREPARATION” tuotevaatimukset hyväksyttiin USA:ssa. Nyt yhtiön ARTEBONE®-tuotteelle on myönnetty patentti kaikissa maissa, joissa sitä on haettu. USA:n osalta on vielä menossa tuotteen valmistusta koskeva patenttihakemus.Covid-19 pandemia aiheutti merkittäviä viiveitä...

MINNEAPOLIS, Feb. 24, 2021 (GLOBE NEWSWIRE) — Jamf (NASDAQ: JAMF), the standard in Apple Enterprise Management, is innovating with new patented workflows to streamline daily tasks and overcome challenges faced by customers in the enterprise, healthcare, and education spaces. Our customers are reaching their highest potentials with Apple devices powered by Jamf, and our current patented workflows are just the beginning. Jamf continues to partner with organizations to identify gaps in their existing workflows and find innovative solutions to fill these gaps and ensure a streamlined end-user process.Virtual VisitsWith Virtual Visits powered by Jamf, healthcare organizations can configure and instantly deploy third-party conferencing platforms like Zoom and Microsoft Teams to iPad or iPhone. Providers are able to virtually round to...

SANTA MARIA, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) — It is with great sadness that the Landec Corporation (Nasdaq: LNDC) announces the death of board member Charles “Mac” Macaluso who passed away on February 22, 2021.“Mac was an outstanding advisor and an integral member of our Board. His breadth of knowledge was critical to rebuilding Curation Foods, our long-term growth strategies that support Lifecore, and our recent successful refinancing,” said Dr. Albert Bolles, Landec’s CEO and President. “It has been a privilege for me and the other Board members to work alongside Mac. He will be greatly missed.”“Mac served our Board with enthusiasm and integrity, and we greatly benefitted from his wisdom and experience. He leaves a legacy of incredible business acumen and passion for excellence that is recognized and appreciated by our...

Press releaseNeuilly-sur-Seine, France – February 24, 2021Bureau Veritas links its syndicated credit facility financial terms to Environmental, Social and Governance (ESG) indicatorsBureau Veritas, a world leader in testing, inspection and certification, announces the signing of an amendment to its EUR 600 million syndicated credit facility − originally signed in 2018 − in order to integrate Environmental, Social and Governance criteria.Bureau Veritas’ social and environmental performance will now be taken into account when calculating the financing cost of its syndicated credit facility. This will be measured against the quantitative ESG objectives that the Group has set for 2025.Didier Michaud-Daniel, Chief Executive Officer of Bureau Veritas, said:“At Bureau Veritas, we contribute to Shaping a World of Trust by helping our clients...

Communiqué de presseNeuilly-sur-Seine, France – 24 février 2021Bureau Veritas indexe les conditions financières de son crédit syndiqué sur des indicateurs Environnementaux, Sociaux et de Gouvernance (ESG)Bureau Veritas, un leader mondial des tests, de l’inspection et de la certification, annonce la signature d’un avenant de son crédit syndiqué d’un montant de 600 millions d’euros signé en 2018, afin d’y intégrer des critères Environnementaux, Sociaux et de Gouvernance.La performance sociale et environnementale de Bureau Veritas sera désormais prise en compte dans le calcul du coût de financement de son crédit syndiqué. Celle-ci sera mesurée à la lumière des objectifs ESG quantitatifs que le Groupe s’est fixés à horizon 2025.Didier Michaud-Daniel, Directeur général de Bureau Veritas, a déclaré :« Chez Bureau Veritas, nous contribuons...

NEXITY: 2020 ANNUAL RESULTSREMARKABLE BUSINESS PERFORMANCE IN BOTH RESIDENTIAL AND COMMERCIAL REAL ESTATEROBUST FINANCIAL PERFORMANCE AND SIGNIFICANT REDUCTION IN DEBTIMPROVED VISIBILITY THANKS TO A €21BN DEVELOPMENT PIPELINEPROPOSED PAYMENT OF A DIVIDEND OF €2 PER SHAREParis, Wednesday, 24 February 2021, 5:45 p.m. CET    2020 FINANCIAL PERFORMANCERevenue up 8% from 2019, totalling €4,855 millionResilience of current operating profit at €285 million (close to 6% margin), thanks to a strong rebound in H2 2020Net financial debt (before lease liabilities) reduced by nearly 30% to €655 million12020 BUSINESS ACTIVITYNew home reservations in France: equivalent level to 2019, with 21,077 units worth €4,515 million including VAT (up 4%); strong growth in market share to almost 17% (up around 3.5 percentage points from 2019) in an overall market...

NEXITY : RÉSULTATS ANNUELS 2020PERFORMANCE COMMERCIALE REMARQUABLE TANT EN IMMOBILIER RÉSIDENTIEL QU’EN IMMOBILIER D’ENTREPRISESOLIDE PERFORMANCE FINANCIÈRE ET FORTE RÉDUCTION DE L’ENDETTEMENTVISIBILITÉ ACCRUE GRÂCE À UN PIPELINE PROMOTION DE 21 MDS €PROPOSITION DE VERSEMENT D’UN DIVIDENDE DE 2 EUROS PAR ACTIONParis, mercredi 24 février 2021, 17h45 CET       RÉSULTATS FINANCIERS 2020Chiffre d’affaires en croissance de 8% par rapport à 2019 à 4.855 millions d’eurosRésistance du résultat opérationnel courant à 285 millions d’euros (près de 6% de taux de marge), grâce à un second semestre en fort rebondEndettement financier net (avant obligations locatives) réduit de près de 30% à 655 millions d’euros1ACTIVITÉ COMMERCIALE 2020Réservations de logements neufs en France : niveau équivalent à 2019 à 21.077 lots pour 4.515 millions d’euros TTC...